BridgeBio Pharma, Inc.
SEC CIK 1743881 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 10% | 14.59M | — | — | 1 | 2025-10-10 | 2025-10-10 |
Most active insiders at BBOT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Elmelech Idan | COO, Principal Financial Ofcr | — | — |
| 2 | Beltran Pedro | Pres, CEO, Dir | — | — |
| 3 | Ben Yong | Chief Med, Dev Off | — | — |
| 4 | Mehra Uneek | Former Off | — | — |
| 5 | Cobo Marc | Principal Accounting Off | — | — |
| 6 | BridgeBio Pharma, Inc. | 10% | — | — |
| 7 | Chen Bihua | Dir, 10% | — | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-16 | 2025-10-10 | BBOT | BridgeBio Oncology Therapeutics, Inc. | BridgeBio Pharma, Inc. | 10% | J - Other | — | +784.7K | 14.59M | +6% | — |
Purchase Sale Sale after option exercise All abbreviations